Organophosphorus compounds (OPCs) have a wide range of applications, from agriculture to warfare. Exposure to these brings forward a varied kind of health issues globally. Terbufos is one of the leading OPCs used worldwide. The present study investigates the cardiac effect of no observable dose of a metabolite of terbufos, terbufos-sulfone (TS), under nondiabetic and streptozotocin-induced diabetic condition. One hundred nanomoles per rat (1/20 of LD 50 ) was administered intraperitoneally to adult male Wister rats daily for fifteen days. The left ventricle was collected for ultrastructural changes by transmission electron microscopy. The blood samples were collected for biochemical tests including RBC acetylcholinesterase, creatinine kinase (CK), lactate dehydrogenase (LDH), cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides, ALT, AST, and GGT. The study revealed about 10 % inhibition of RBCAChE in two weeks of TS treatment in non-diabetic rats whereas RBC-AChE activity was significantly decreased in diabetic TS treated rats. CK, LDH, and triglycerides were significantly higher in diabetic TS treated rats. Electron microscopy of the heart showed derangement and lesions of the mitochondria of cardiomyocytes in the TS treated groups. The present study concludes that a non-lethal dose of TS causes cardiac lesions which exacerbate under diabetic condition. Biochemical tests confirmed the ultrastructural changes. It is concluded that a non-lethal dose of TS may be a risk factor for a cardiovascular disease, which may be fatal under diabetic condition.
Organophosphorus compounds (OPCs) are used in agriculture as insecticides, pesticides, helminthicides, acaricides, nematocides, and herbicides. Furthermore, they are used as a warfare agent and in controlling disease vectors for public health purposes. Over the years, the use of OPCs has increased dramatically with new applications still being developed. To date, there are over 100 different OPCs available, with a similar generalised chemical structure. Wide accessibility, along with indiscriminate and inadvertent use or exposure, may result in intentional poisoning or unintentional toxicity and it therefore poses a risk to the users and workers involved in their production and application. The acute toxicity of different OPCs ranges from that of an extremely toxic nerve gas to less than that of table salt. Toxicity of all OPCs is due to irreversible i n h i b i t i o n o f t h e n e u r o t r a n s m i t t e r e n z y m e acetylcholinesterase (AChE).
A significant association between OPC exposure and toxic effects on different organs has been reported in numerous epidemiological studies (1) (2) (3) . Among several toxic manifestations, cardiotoxicity is believed to be one of the unrecognised risk factors of OPCs. The effects of OPCs on the cardiovascular system are speculative or based on individual clinical case reports (4) (5) (6) (7) . The risk of exposure to sub-acute low levels of OPCs for the heart has been scarcely addressed and somehow did not garner much attention from researchers. Albeit, only electrophysiological alterations have been reported but morphological maladies have barely been touched upon. The nature of their toxic effects is variable ranging from transient to permanent (8) . It is noteworthy that cardiotoxicity with OPCs may be independent of AChE inhibition. For instance, dimethoate toxicity in guinea pigs has been reported to cause cardiac failure without any effect on AChE inhibition (9) . Likewise, studies also suggest that toxicity of OPCs causes mitochondrial dysfunction mediating a non-cholinergic mechanism (10) .
Simultaneously, cardiovascular diseases are increasing significantly globally, as is the prevalence and incidences of diabetes mellitus (DM), one of the important risk factors for cardiovascular diseases. Taken all together, diabetes and cardiovascular diseases are predicted to increase even further over the next decades. Hence, it is reasonable to predict that exposure to OPCs may have a significant impact on the manifestations of cardiotoxicity in patients with diabetes and prediabetes much faster than in normal healthy individuals. It may be noted that the effect of OPCs under diabetic pathological condition is scarcely reported (11, 12) .
Therefore, the present study was carried out to investigate the effect of sub-acute exposure to terbufos sulfone (TS), a highly toxic OPC as per the World Health Organization (WHO) classification of insecticides and pesticides. Terbufos is registered in more than 20 countries; however, its usage has been banned in Europe since 2006. The present study was designed to demonstrate whether TS relevant to no-observable adverse effect level (NOAEL) dose could exacerbate cardiac injury in non-diabetic and streptozotocin-induced (STZ) diabetic rats. This study will have significant implications because sub-acute exposure to TS or to any other OPC has inadequately been addressed in the literature.
MATERIALS AND METHODS

Experimental animals
The original stock of Wistar rats were purchased from Harlan Laboratories (Harlan Laboratories, Oxon, England). The animals used in the actual experiments were bred at our own animal facility from the original stock. Male adult rats, weighing 200-250 g were used in the present study. The animals were housed in polypropylene cages (43x22.5x20.5 cm; six rats per cage) in climate and access controlled rooms maintained under standard laboratory conditions (temperature: 23±1 °C; humidity: 50±4 %; day/ night cycle: 12h/12h). The rodent pellet diet was procured from the Emirates Feed Factory, Abu Dhabi, UAE and water was available ad libitum. All the experimental procedures were in strict compliance with the protocol approved by the institutional animal ethics committee for the care and use of laboratory animals (Ethical Approval #A2-13).
Induction of experimental diabetes mellitus
To induce type I diabetes, after an overnight fast, the rats were administered a single intraperitoneal (i.p.) injection of streptozotocin (60 mg kg -1 body weight) prepared freshly in citrate buffer (0.1 mol L -1 pH 4.5) solution. The induction of diabetes in rats was confirmed measuring random blood glucose levels using a One-Touch Glucometer (Lifescan Inc., Milpitas, CA, USA). Animals with blood glucose above 235 mg dL -1 were considered diabetic and were used further for the experiments.
Experimental design
There were four experimental groups, each containing 6 rats. Terbufos sulfone (TS) was administered i.p. at a dose of 100 nmol per rat (1/20 of LD 50 ) following our previous laboratory studies (13) . The animals were treated daily for two weeks. Group 1 (G1): Non-diabetic control (saline-treated nondiabetic rats) Group 2 (G2): Diabetic control group (No treatment with TS) Group 3 (G3): Non-diabetic group, treated with 100 nmol of TS Group 4 (G4): Diabetic group, treated with 100 nmol of TS
Chemicals
The TS stock solution (100 mmol L -1 ) was prepared in dry acetone. The working solution for the i.p. injection was prepared extempore by diluting the stock solution with physiological saline. The chemicals, TS and streptozotocin, were purchased from Sigma-Aldrich Chemie (SigmaAldrich Chemie GmbH, Steinheim, Germany).
Blood glucose measurement
Random blood glucose was checked on day 8 of each week before the injection of TS. Blood samples were collected from the tail vein.
RBC-AChE activity
The blood sample for RBC-AChE measurement was collected from the tail vein of the animal. The RBC-AChE activity was measured in diluted whole blood samples in the presence of a selective butyrylcholinesterase inhibitor, ethoproprazine, as described previously (14) .
Blood collection for biochemical tests
The blood samples were collected from rats before decapitation and were subsequently centrifuged at 2555 g for 10 minutes. The obtained serum was then stored frozen at -80 °C. The markers for cardiac function viz. myocyte 
injury marker enzymes such as lactate dehydrogenase (LDH) and creatinine kinase (CK), for lipid profile such as cholesterol, triglycerides, high density lipoprotein (HDL), low density lipoprotein (LDL), and liver function enzymes such as alanine transaminase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) were measured by an autoanalyser (COBAS INTEGRA 400 PLUS from Roche Diagnostics, Germany).
Transmission electron microscopy
The left ventricle from the heart of animals of each experimental group was cut into small pieces and fixed for 5 hours in 2.5 % glutaraldehyde in Karnovsky's solution (15) . The samples were washed overnight in cacodylate buffer (40 °C) and post fixed with 1 % osmium tetroxide for 1 hour. The samples were further washed six times in cacodylate buffer and dehydrated in ethyl alcohol at graded concentrations. They were later treated with propylene oxide; two changes of 15 minutes and were then immersed in propylene oxide and resin (1:1) for 1 hour followed by pure resin overnight. Afterwards, the samples were embedded and polymerised at 60 °C for 24 hours. Semi and ultrathin sections were cut using a diatome knife procured from Agar Scientific, Essex, England. The semi thin sections were placed on glass slides and stained with toluidine blue. The ultrathin sections were mounted on 3.05 mm 200 mesh copper grids and contrast stained first with saturated aqueous uranyl acetate for 30 min and then with Renold's lead citrate for 5 minutes. The ultrathin sections were viewed under a Philips CM10 transmission electron microscope (Eindhoven, The Netherlands).
Statistical analysis
Statistical analysis was performed for all the parameters obtained from the experimental groups using SPSS 21.0 (SPSS Inc., Chicago, IL, USA). To determine the significance in comparison to control values, the MannWhitney order rank test was used. The limit of statistical significance was set at p<0.05. Figure 2 shows the change in body weight of experimental animals after the first and second weeks of saline (controls) and TS treatment. The non-diabetic animals increased body weight over time irrespective of whether treated with saline or TS. The diabetic animal groups decreased their body weight. This decrease was more conspicuous in the TS treated than in the saline treated group. However, the change was not found statistically significant compared to the pre-treatment or first-week body weight.
RESULTS
Body weight
Blood glucose
Random blood glucose levels across G1 to G4, over a period of two weeks, are depicted in Figure 3 . The average two-week blood glucose levels in G1 and G2 (control groups) were 100±9 mg dL -1 and 473±72 mg dL -1 , respectively. The average two-week blood glucose level in G3 was 100±8 mg dL -1 . The mean blood glucose level for diabetic rats treated with TS100 (G4) was 511±29 mg dL -1 over the two-week period. This increase was statistically significant (p<0.05) compared to the pre-treatment value (432±29 mg dL -1 ).
RBC-Acetylcholinesterase
The activity of RBC-AChE enzyme was determined as a percentage of baseline and is depicted in Figure 4 . The intraperitoneal injection of 100 nmol of TS administered to non-diabetic rats (G2) did not produce a significant change in the RBC-AChE activity. The same dose in STZinduced diabetes (G4) produced a sharp and statistically significant decrease (p<0.05) in week 1 (38 %±18) and week 2 (11 %±3). The diabetic control group (G3) showed a moderate decrease which was statistically not significant.
The ultrastructure of the heart (transmission electron microscopy)
The ultrastructure of the heart by transmission electron microscopy is represented in Figure 5 . A representative image of the ultrastructure of the heart of non-diabetic control rats is represented in Figure 5A . Myofibrils were observed intact with thick and definite architecture and linearly arranged mitochondria. Figure 5C shows the ultrastructure of the heart of non-diabetic TS treated rats. A distorted architecture of myofibrils, large intermyofibrillar spaces and swollen mitochondria are conspicuous and are the effect of TS treatment. Figure 5B shows the diabetic control group. Thin myofibril, deranged mitochondria, and inter-myofibrillar spaces are a characteristic pathological effect of diabesity. The mitochondria (m) of the cardio myocytes of the heart of diabetic rats treated with TS ( Figure 5D ) contain deranged mitochondria (m) and large muscle inter-fibre spaces. Mitochondrial lesions were more conspicuous in diabetic rats ( Figure 5D ) when compared to those of the non-diabetic and diabetic control groups ( Figure 5A & B) , and TS treated non-diabetic ( Figure 5C ) rats. A damaged architecture of myofibrils was clearly observable between the TS treated and non-treated groups though diabetes itself damages the heart structure. Table 1 shows the creatine kinase (CK) and lactate dehydrogenase (LDH) levels in the control and TS treated groups after two weeks of treatment. CK and LDH levels were found significantly elevated (p<0.05) in the diabetic TS treated groups, indicating a cardiac manifestation of TS treatment. Table 2 shows the measurement of cholesterol, HDL, LDL, triglycerides, ALT, AST, and GGT in the serum of the treated and non-treated groups. The non-diabetic TS treated groups did not show statistical significance (Table  3) in the alteration of the tested parameters when compared to their corresponding non-diabetic saline control except for AST, which decreased significantly. However, diabetic rats treated with TS showed marked and statistically significant (p<0.05) changes in all the tested parameters except for ALT, which was found to be non-significantly different than in the diabetic saline control group. Among all the parameters of the lipid profile, triglycerides markedly surged in the diabetic TS treated group (mean±SD: 1.61±0.79) compared to the diabetic and non-diabetic controls (mean±SD: 0.60±0.12, 0.90±0.40 respectively).
CK and LDH
Lipid profile
DISCUSSION
The present study demonstrates that even a relatively non-lethal dose of terbufos sulfone and sub-acute exposure to it causes toxic effects to the heart of non-diabetic and STZ-induced diabetic rats. Terbufos belongs to an extremely toxic group of OPCs as per the WHO's classification of hazardous chemicals (16) and its metabolites are also . TS is the active metabolite of terbufos, the fourth most frequently used pesticide in the USA, reported for its use in fish kill incidents, which is also suggestive of its presence in the food chain (17) . To the best of our knowledge and based on the available literature, no data on the cardiovascular condition following sub-acute exposure to this compound has been reported. Hundreds of different OPCs share a common mechanism of action but are toxicologically different one from the other, ranging from deadly poison nerve agents to those with virtually no toxic potential (18) . According to the website Scorecard (19) , the list of more than 500 cardiovascular toxins causing different types of cardiovascular complications contains only few OPCs. This list reflects the paucity of studies with OPCs. Asymptomatic low-level exposure to OPCs has been reported to cause various health effects including cardiac lesions (8, 20, 21) . Different individual toxicokinetics of OPCs necessitates investigating the effect on the heart under normal and diabetic conditions (22) . The cardiovascular manifestation of OPC poisoning is mainly attributed to acute poisoning (23-27), which comprises bradycardia or tachycardia or impaired heart rate. There are reports showing an increased level of creatine kinases and lactate dehydrogenases, besides myocardial necrosis (28) . The results of the present study reveal that TS causes a leakage of myocyte injury marker enzymes into the serum, as evidenced by the elevated levels of serum CK and LDH. The structural change in the heart was further correlated with the myocyte injury marker enzymes' leakage from cardiomyocytes to the serum. Abdou et al. (29) reported increased LDH and histologically large areas of degenerating muscle fibres with an evident loss of transverse striations and wide inter-fascicular spaces when treated with diazinon, an OPC. Velmurugan (30) used 1/50 th of LD 50 dosage of monochrotophos against Wister rats and found elevated LDH and CK-MB in the blood plasma along with signs of nonspecific inflammatory changes and oedema between muscle fibres of the heart. The present study also investigated ultrastructural changes following the administration of a non-lethal dose of TS to non-diabetic and STZ-induced diabetic rats. Ultrastructural changes after acute OPC poisoning have been reported by numerous clinical case studies (31) (32) (33) (34) . We also observed similar cardiac lesions in diabetic rats with sub-acute and apparently non-lethal exposure to TS. The injurious effect on the heart in diabetic rats was further confirmed by low HDL and high triglycerides. These observations are in line with other previous studies which report that exposure to repeated doses of profenfos, an OPC, significantly increased LDH and CK enzymes (35) . The probable reason for this leakage could be cell death as Razavi et al. (36) reported with sub-chronic exposure to diazinon, an organophosphate. In the present study, we also observed that TS administration led to a structural impairment of the mitochondrion in non-diabetic TS treated rats, but the lipid profile was not significantly affected. This observation was supported by a previous study wherein a higher but non-lethal dose of 20 mg kg -1 body weight of diazinon administered for four weeks did not reveal a change in the cholesterol and triglyceride levels (37) .
OPC elicits its toxicity by inhibiting acetylcholinesterase. The severity of poisoning depends upon the extent of AChE inhibition and consequent cholinergic crises. This may be correlated with the observation that inhibition of AChE was severe in diabetic rats at the end of the second week and it resembled acute toxicity. The effect of anticholinesterases on the heart is mainly attributed to acute toxicity, especially the delayed or late phase effect (5) . Different mechanisms and pathways have been reported to be involved in the cardiotoxicity of acute OPC poisoning. One of the studies suggests that morphologic damage may be instigated by uninterrupted vagus nerve stimulation of the accumulated acetylcholine (5) . Herein, the magnitude of myocardial damage correlated with the duration of exposure. It has also been found that cardiac damage may be independent of the extent of AChE inhibition contrary to the high level inhibition of AChE in acute poisoning. Since acetylcholine receptors have a high binding capacity for calcium ions (38) , the disorder of cellular morphology may be ascribed to a massive influx of Ca 2+ into the cytoplasm. The results also signify that TS even after two weeks has a potential to raise triglyceride levels, cause myocyte injury and subsequent myocardial injury. Interestingly, the changes observed were irrespective and independent of the degree of AChE inhibition, as it was observed to be high in diabetes and low in non-diabetic rats. This suggests that occupational exposure to TS, even at low doses, may pose a risk in those who are prone to develop diabetes and can worsen cardiotoxic manifestations in diabetics. In addition, ultra-structural studies may be a vital tool in identifying the non-lethal dose associated cardiac effect, since biochemical changes may be not evident at such dose or can manifest after very long exposure. Considering the high rise of diabetes and cardiovascular diseases, the exposure to TS may impact cardiovascular health, worsen the disease condition and accelerate progression.
CONCLUSION
TS at a relatively non-lethal dose may be associated with cardiovascular complications including myofibril degeneration, wide inter-fascicular spaces, and mitochondria mutilation. The impact may become exacerbated under diabetic condition, which may lead to mortality and morbidity. The effect may be independent of ACh inhibition as observed in non-diabetic rats or might be related to ACh inhibition, as was seen in diabetic rats.
Terbufos sulfon pogoršava srčane lezije u štakora koji boluju od dijabetesa: studija subakutne toksičnosti Organofosforni spojevi (eng. Organophosphorous Compounds -OPCs) imaju široku primjenu, od one u poljoprivredi do one u vojne svrhe. Izlaganje takvim spojevima izaziva niz različitih zdravstvenih problema od globalnog značaja. Terbufos je jedan od vodećih OPC-a koji se koriste diljem svijeta. U ovom je istraživanju na modelu štakora bez dijabetesa i sa streptozotocinom izazvanim dijabetesom ispitivan metabolit terbufos-sulfon (TS) u najvišoj dozi koja ne izaziva učinak te njezin utjecaj na srce. Odrasli mužjaci štakora soja Wistar dobivali su petnaest dana dnevnu dozu od 100 nmol štakor -1 (1/20 LD 50 ) intraperitonealno. Transmisijskim elektronskim mikroskopom istražene su ultrastrukturne promjene lijeve klijetke. Na krvnim uzorcima provedeni su biokemijski testovi, uključujući aktivnost acetilkolinesteraze u crvenim krvnim stanicama, razinu kreatinin kinaze (CK), laktat dehidrogenaze (LDH), kolesterola, lipoproteina visoke gustoće (HDL), lipoproteina niske gustoće (LDL), triglicerida, ALT, AST i GGT. Istraživanjem je otkriveno oko 10 % inhibicije AChE-a u crvenim krvnim stanicama nakon dva tjedna izlaganja štakora bez dijabetesa TS-u, dok je u štakora s dijabetesom aktivnost AChE-a bila značajno smanjena. Razine CK, LDH i triglicerida bile su značajno više u TS tretiranim štakorima s dijabetesom. Elektronsko-mikroskopska analiza srca upućuje na narušenu strukturu i lezije u mitohondrijima u kardiomiocitima skupina štakora koji su tretirani TS-om. Zaključuje se da nesmrtonosna doza TS-a uzrokuje srčane lezije koje se pogoršavaju u prisutnosti dijabetesa. Biokemijski testovi potvrdili su ultrastrukturne promjene. Navedena doza TS-a može biti rizični čimbenik za kardiovaskularne bolesti, koje se mogu pokazati smrtonosnima uz istovremeno postojanje dijabetesa.
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